Kolexia
Heliot-Marcelin Anne-Genevieve
Pharmacien
Hôpital Pitie Salpetriere
Paris, France
428 Activités
1.1 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Infections à VIH COVID-19 Virémie Sarcome de Kaposi Sarcomes Hépatite C Hépatite Séropositivité VIH Syndrome d'immunodéficience acquise

Industries

ViiV Healthcare
33 collaboration(s)
Dernière en 2023
Gilead
14 collaboration(s)
Dernière en 2023
Theratechnologies International Limited
8 collaboration(s)
Dernière en 2021
GSK
8 collaboration(s)
Dernière en 2022

Dernières activités

Low unspliced cell-associated HIV RNA in early treated adolescents living with HIV on long suppressive ART.
Frontiers in immunology   20 février 2024
Evaluation of Biological Response to SARS-COV2 (COVID-19) in Patients With Pre-existing Neurological Disease or Newly Neurological Symptoms (BIO-COCO-NEUROSCIENCES): Evaluation of Biological Response to SARS-COV2 in Patients With Pre-existing Neurological Disease or With New Neurological Manifestations of COVID-19
Essai Clinique (Assistance publique – Hôpitaux de Paris)   01 février 2024
Use of genotypic HIV DNA testing: a DELPHI-type consensus.
The Journal of antimicrobial chemotherapy   23 janvier 2024
Extending vaccination periods against human papillomavirus: Lessons from the SARS-CoV-2 pandemic.
BJOG : an international journal of obstetrics and gynaecology   15 janvier 2024
Prevalence and phenotypic susceptibility to doravirine of the HIV-1 reverse transcriptase V106I polymorphism in B and non-B subtypes.
The Journal of infectious diseases   11 janvier 2024
DORAVIR: A French national survey of people with HIV-1 treated by an antiretroviral regimen including Doravirine
HIV medicine Congress 2023   01 décembre 2023
Dolutegravir/rilpivirine (DTG/RPV) therapy as a maintenance treatment in PLWH with past virological failures and resistance-associated mutations to NNRTIs and INSTIs
HIV medicine Congress 2023   01 décembre 2023
3-year analysis of emergent resistance-associated mutations at first- or second-line HIV-1 virologic failure with second generation INSTIs in 2- and 3-drug regimens (Virostar study)
HIV medicine Congress 2023   01 décembre 2023
Spike protein genetic evolution in patients at high-risk of severe COVID-19 treated by monoclonal antibodies.
The Journal of infectious diseases   23 novembre 2023
Higher levels of SARS-CoV-2 genetic variation in immunocompromised patients: a retrospective case-control study.
The Journal of infectious diseases   13 novembre 2023